0001375151-18-000055.txt : 20180705
0001375151-18-000055.hdr.sgml : 20180705
20180705160603
ACCESSION NUMBER: 0001375151-18-000055
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180702
FILED AS OF DATE: 20180705
DATE AS OF CHANGE: 20180705
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Sagrolikar Ashish M
CENTRAL INDEX KEY: 0001745512
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-34962
FILM NUMBER: 18940626
MAIL ADDRESS:
STREET 1: C/O ZOGENIX, INC.
STREET 2: 5858 HORTON STREET, #455
CITY: EMERYVILLE
STATE: CA
ZIP: 94608
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ZOGENIX, INC.
CENTRAL INDEX KEY: 0001375151
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 205300780
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 5858 HORTON STREET, #455
CITY: EMERYVILLE
STATE: CA
ZIP: 94608
BUSINESS PHONE: (510) 550-8300
MAIL ADDRESS:
STREET 1: 5858 HORTON STREET, #455
CITY: EMERYVILLE
STATE: CA
ZIP: 94608
FORMER COMPANY:
FORMER CONFORMED NAME: ZOGENIX INC
DATE OF NAME CHANGE: 20060911
4
1
wf-form4_153082114709959.xml
FORM 4
X0306
4
2018-07-02
0
0001375151
ZOGENIX, INC.
ZGNX
0001745512
Sagrolikar Ashish M
C/O ZOGENIX, INC.
5858 HORTON STREET, SUITE 455
EMERYVILLE
CA
94608
0
1
0
0
EVP & CHIEF COMMERCIAL OFFICER
Restricted Stock Units
2018-07-02
4
A
0
15000
0
A
15000
D
Stock Option (Right to Buy)
43.7
2018-07-02
4
A
0
100000
0
A
2028-07-01
Common Stock
100000.0
100000
D
Issued pursuant to Zogenix's Employment Inducement Equity Incentive Award Plan.
Each restricted stock unit (RSU) represents a contingent right to receive one share of Zogenix common stock. The RSUs shall vest over a four-year period at the rate of 25% of the RSUs on each of the first four anniversaries of the date of grant, subject to the Reporting Person's continued service with Zogenix on each vesting date.
The options shall vest over a four-year period, with 25% of the options vesting on the first anniversary of the date of grant and the remainder vesting in equal monthly installments over the three years thereafter, subject to the Reporting Person's continuous service to Zogenix on each vesting date.
/s/ Thomas Doyle, Attorney-in-fact for Ashish Sagrolikar
2018-07-05